Topics

Companies Related to "Approves Celgene Reblozyl Treatment Anemia Adults with Beta" [Most Relevant Company Matches] [Advanced Search Results] RSS

18:55 EST 17th January 2020 | BioPortfolio

Here are the most relevant search results for "Approves Celgene Reblozyl Treatment Anemia Adults with Beta" found in our extensive corporate database of over 50,000 company records.

Showing "Approves Celgene Reblozyl Treatment Anemia Adults with Beta" Companies 1–25 of 3,800+

Relevant

DACOGEN

DACOGEN is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British (FAB) subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and i...


Celgene International Sàrl

Celgene International Sàrl, located in Boudry, in the Canton of Neuchâtel, Switzerland, is a wholly owned subsidiary and international headquarters of Celgene Corporation. Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global pharmaceutical company engaged primarily in the discovery, development and commercialization of in...

Celgene Cellular Therapeutics

Celgene International Sàrl, located in Boudry, in the Canton of Neuchâtel, Switzerland, is a wholly owned subsidiary and international headquarters of Celgene Corporation.


Aranesp

Aranesp® (darbepoetin alfa) is indicated for the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis, and for the treatment of anemia in patients with nonmyeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.Important Product Safety InformationAranesp® is contraindicated in patien...

AMAG Pharmaceuticals, Inc.

GENOVO Incorporated

Gene therapy using viral vectors for the treatment of cancer, anemia, hepatitis and diabetes.

Beta Amyloid Org

Beta Amyloid.org keeps up details of Alzheimer Research Labs, Alzheimer Research conferences around the world. Amyloid peptides being one of the major culprit of the Alzheimer Disease so our goal is to provide anything and everything to the researchers at one website. Beta Amyloid.org access is totally free; however, we don’t endorse any scientific information. Our team of scientists, editors an...

BETA Healthcare Group

BETA Healthcare Group provides healthcare professional liability coverage to more than 150 hospitals and healthcare facilities in California. As the leading choice of liability insurers for California hospitals, BETA’s long-established commitment to California physicians continues to grow with more than 5,000 insured physicians and over 70 medical gro...

HAND & NERVE specialists

HAND & NERVE specialists is a multidisciplinary group dedicated to the comprehensive treatment and rehabilitation of children and adults with complex disorders, both congenital and acquired, of the upper extremity. The program has special expertise and extensive experience in the management of Brachial Plexus Injuries in children and adults. Although based in Miami, Florida, by special arrangement...

Beta-Cell

Beta-Cell is engaged in the development and commercialisation of innovative cell and drug therapies for the treatment of diabetes. The primary therapeutic focus of the company is on beta-cells, the highly specialized endocrine cells located in pancreatic islets and responsible for producing insulin. Beta-Cell has an advanced pre-clinical xeno-transplantation program based on its proprietary techno...

Akebia Therapeutics, Inc.

Akebia Therapeutics is a discovery and development company focused on anemia and vascular disorders. Akebia’s lead program, AKB-6548, an orally bioavailable HIF-prolyl hydroxylase (HIF-PH) inhibitor for patients with anemia, is in phase 2 clinical trials. AKB-6548 potentially promises to be a safer, less expensive, orally dosed pharmaceutical to stimu...

McNeil Pediatrics(TM)

McNeil Pediatrics(TM), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., is committed to meeting the needs of children, adolescents, adults and healthcare professionals through the development of therapies specifically formulated for children, adolescents and adults. McNeil Pediatrics(TM) is a leader in the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and markets a leading me...

Ligand Pharmaceuticals Incorporated

Ligand discovers and develops new drugs that address critical unmet medical needs of patients for a broad spectrum of diseases including hepatitis, muscle wasting, Alzheimer's, inflammatory diseases, anemia, COPD, asthma, rheumatoid arthritis and osteoporosis. Ligand's proprietary drug discovery and development programs are based on advanced cell-based ass...

Beta Technology Ltd

Beta Technology Ltd is a private company established in 1984, by Dr Bob Keown OBE. Originally a lecturer in Metallurgy at Sheffield University, Bob set up his own consultancy company in 1984 and later went on to set up an employment agency hiring out scientists to industry such as British Steel (Corus), the National Physical Laboratory (NPL) and the Central Science Laboratory (CSL).Since then the ...

Caron Treatment Centers

Caron Treatment Centers is a nationally recognized non-profit provider of alcohol and drug addiction treatment. With more than 50 years in the field, Caron is one of the oldest and largest facilities offering primary, relapse and extended residential treatment for young adults, adults and adolescents, as well as families affected by the disease of addiction. Caron's gender separate and gender spec...

Neurogen Corporation & Ligand Pharmaceuticals

Ligand discovers and develops new drugs that address critical unmet medical needs of patients with muscle wasting, frailty, hormone-related diseases, osteoporosis, inflammatory diseases, anemia, asthma, rheumatoid arthritis and psoriasis. Ligand's proprietary drug discovery and development programs are based on advanced cell-based assays, gene-expression t...

Ortho Biotech

In 1990, Ortho Biotech was established as the first biotechnology subsidiary of Johnson & Johnson.Today, our products and treatments combat some of the most serious diseases - such as cancer, HIV/AIDS, and chronic kidney disease. They also help restore the health and comfort of patients undergoing elective surgery, organ transplants, and chemotherapy.We are a leader in the worldwide treatment of a...

Acceleron Pharma, Celgene Corporation

Acceleron is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair. The company is a leader in understanding the biology of the TGF-beta protein superfamily, a large and diverse group of molecules that are key regulators in the growth a...

Celgene Corporation

Celgene is a pharmaceutical company with a major focus on the discovery, development and commercialization of small molecules for cancer and immunological diseases.Celgene's medical research and development team is working to extend the boundaries in the areas of small molecule immunotherapeutic and biocatalytic chiral chemistry by developing both new pharmaceuticals and chirally pure versions of ...

Acceleron Pharma & Celgene Corporation

Acceleron is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair. The company is a leader in understanding the biology of the TGF-beta protein superfamily, a large and diverse group of molecules that are key regulators in the growth a...

EPOGEN® (Epoetin alfa)

EPOGEN® (Epoetin alfa), one of the first biologic human therapeutics, is approved for the treatment of anemia in patients with chronic kidney disease who are on dialysis.

HopeWay

HopeWay is an accredited nonprofit residential and day mental health treatment center for adults located in South Charlotte and serving clients from the Charlotte region and from across the nation. HopeWay’s continuum of care meets the needs of adults living with mental illness and their families with residential care and day treatment programs as wel...

Celgene Corporation and BeiGene, Ltd.

Forbius

Forbius is a clinical stage company that designs and develops biotherapeutics for the treatment of cancer and fibrotic diseases. Forbius’ medicines are designed to radically transform patients’ lives. We use our strength in biological understanding and diverse protein engineering technologies to design superior inhibitors of validated pathways. W...

Aranesp® (darbepoetin alfa)

Aranesp® (darbepoetin alfa) is approved for the treatment of anemia associated with chronic kidney disease and chemotherapy.


More From BioPortfolio on "Approves Celgene Reblozyl Treatment Anemia Adults with Beta"

Quick Search

Corporate Database Quicklinks